Lipid-lowering and antiaggregatory efficacy of atorvastatin in coronary heart disease patients with combined hyperlipidemia

被引：0
|
作者：
Viigimaa, M [1 ]
Välkman, R [1 ]
机构：
[1] Tartu Univ Hosp, Dept Cardiol, Tartu, Estonia
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80089-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [1] The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia
    Chang, Chwen-Tzuei
    Lee, Jenn-Kuen
    Lin, Jen-Der
    Hung, Yi-Jen
    Liu, Rue-Tsuan
    Shau, Wen-Yi
    Sheu, Wayne Huey-Herng
    [J]. TZU CHI MEDICAL JOURNAL, 2013, 25 (03): : 168 - 174
  • [2] Lipid-lowering efficacy of atorvastatin
    Adams, Stephen P.
    Tsang, Michael
    Wright, James M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
  • [3] Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
    Cheng, Quankai
    Sun, Jingjing
    Zhong, Haicheng
    Wang, Ziming
    Liu, Chang
    Zhou, Sheng
    Deng, Jie
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] Intensive lipid-lowering therapy in patients with coronary heart disease
    Lauderdale, SA
    Sheehan, AH
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (02) : 329 - 334
  • [5] The Lipid-Lowering Effect of Atorvastatin in Acute Coronary Syndrome Patients
    Ying, Ku Ming
    Tan, S. S. N.
    Tan, C. S. Y.
    Tiong, L. L.
    Lim, A. M. W.
    Ling, D. E.
    Hii, E. H. H.
    Kiu, I. S. N.
    Wong, L. W.
    Ting, M. L. L.
    Sumbai, M. E.
    Chua, A. T. P.
    Douglas, J. S.
    Theng, M. L.
    Chew, S. W.
    Fong, A. Y. Y.
    Ong, T. K.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 7 - 8
  • [6] Lipid-lowering effect of atorvastatin in heart transplantation
    Bonet, LA
    Martínez-Dolz, L
    Vives, MAA
    Soriano, JR
    Sáez, AO
    Gisbert, FD
    Pérez, MP
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 179 - +
  • [7] Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
    Steffens, Daniel
    Bramlage, Peter
    Mueller, Julia
    Dorn, Cornelia
    Paar, W. Dieter
    Scheeff, Celine
    Kasner, Mario
    Rauch-Kroehnert, U.
    [J]. OPEN HEART, 2021, 8 (01):
  • [8] LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
    Ostergren, J.
    Malmstrom, R.
    Jorgensen, L.
    Walldius, G.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 205 - 205
  • [9] Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease
    Shepherd, James
    Kastelein, John J. P.
    Bittrier, Vera
    Deedwania, Prakash
    Breazna, Andrei
    Dobson, Stephen
    Wilson, Daniel J.
    Zuckerman, Andrea
    Wenger, Nanette K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) : 1448 - 1454
  • [10] Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease
    Wittlinger, Thomas
    Schwaab, Bernhard
    Voeller, Heinz
    Bongarth, Christa
    Heinze, Viktoria
    Eckrich, Kristina
    Guha, Manju
    Richter, Michael
    Schlitt, Axel
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (09)
12345